Reported 2 days ago
Intuitive Surgical, Inc. (NASDAQ:ISRG) has garnered positive attention from Wall Street following its strong fiscal Q2 2025 results, which showed a 21.40% revenue increase year-over-year. Analysts project a 26.42% upside with an average 12-month price target of $597. Analysts from Leerink Partners and Piper Sandler have maintained 'Buy' ratings, citing significant revenue growth and increased placements of the da Vinci surgical system. The company also anticipates a slight growth adjustment in worldwide da Vinci procedures for 2025.
Source: YAHOO